Literature DB >> 4211693

[The binding of 4-(2'-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic acid dimethyl ester (nifedipine) as well as other coronary active substances to serum albumins].

H Rosenkranz, K Schlossmann, W Scholtan.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4211693

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


× No keyword cloud information.
  9 in total

Review 1.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

2.  Effects of calcium channel blockers on the development of early rat postimplantation embryos in culture.

Authors:  G Stein; M K Srivastava; H J Merker; D Neubert
Journal:  Arch Toxicol       Date:  1990       Impact factor: 5.153

3.  Effects of hyperlipidemia on the pharmacokinetics of nifedipine in the rat.

Authors:  L A Eliot; R T Foster; F Jamali
Journal:  Pharm Res       Date:  1999-02       Impact factor: 4.200

4.  Haemodialysis does not affect the pharmacokinetics of nifedipine.

Authors:  H Martre; R Sari; A M Taburet; C Jacobs; E Singlas
Journal:  Br J Clin Pharmacol       Date:  1985-08       Impact factor: 4.335

Review 5.  Nifedipine. Relationship between pharmacokinetics and pharmacodynamics.

Authors:  C H Kleinbloesem; P van Brummelen; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1987-01       Impact factor: 6.447

Review 6.  Clinical pharmacokinetics of verapamil, nifedipine and diltiazem.

Authors:  H Echizen; M Eichelbaum
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

7.  Stereoselective pharmacokinetics of oral felodipine and nitrendipine in healthy subjects: correlation with nifedipine pharmacokinetics.

Authors:  P A Soons; T M Mulders; E Uchida; H C Schoemaker; A F Cohen; D D Breimer
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

8.  Influence of haemodialysis on the pharmacokinetics and haemodynamic effects of nifedipine during continuous intravenous infusion.

Authors:  C H Kleinbloesem; P van Brummelen; A J Woittiez; H Faber; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

9.  Total and free steady-state plasma levels and pharmacokinetics of nifedipine in patients with terminal renal failure.

Authors:  L van Bortel; R Böhm; J Mooij; P Schiffers; K H Rahn
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.